Atlas Trials

Long-Term Follow-up of Subjects Who Were Treated With ST-920

Clinical trial NCT05039866 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05039866
Sponsor
Sangamo Therapeutics
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Fabry DiseaseFabry Disease, Cardiac Variant
Start date
2021-08-16
Primary completion
2029-03-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.